Global Cyanocobalamin Market Survey and Trend Research 2018

September 2018 | 73 pages | ID: G0D7C2A3031EN
99Strategy

Abstracts

Summary

Cyanocobalamin is a man-made form of vitamin B12. Vitamin B12 is important for growth, cell reproduction, blood formation, and protein and tissue synthesis.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Luitpold Pharmaceuticals, Luitpold Pharmaceuticals (Daiichi Sankyo), Endo International, Bristol-Myers Squibb, Jamieson, Jamieson, Teva (Actavis), Merck, Mylan, Bayer HealthCare, Pfizer, ANGELINI, Biological E, CCEPCD, Huaxin Pharmaceutical etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Cyanocobalamin Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 CYANOCOBALAMIN MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Luitpold Pharmaceuticals (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Luitpold Pharmaceuticals (Daiichi Sankyo) (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Endo International (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Jamieson (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Jamieson (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Teva (Actavis) (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Merck (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Mylan (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Bayer HealthCare (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Pfizer (Company Overview, Sales Data etc.)
4.12 ANGELINI (Company Overview, Sales Data etc.)
4.13 Biological E (Company Overview, Sales Data etc.)
4.14 CCEPCD (Company Overview, Sales Data etc.)
4.15 Huaxin Pharmaceutical (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Cyanocobalamin Market 2012-2017, by Type, in USD Million
Table Global Cyanocobalamin Market Forecast 2018-2023, by Type, in USD Million
Table Luitpold Pharmaceuticals Overview List
Table Cyanocobalamin Business Operation of Luitpold Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Luitpold Pharmaceuticals (Daiichi Sankyo) Overview List
Table Cyanocobalamin Business Operation of Luitpold Pharmaceuticals (Daiichi Sankyo) (Sales Revenue, Cost, Gross Margin)
Table Endo International Overview List
Table Cyanocobalamin Business Operation of Endo International (Sales Revenue, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Cyanocobalamin Business Operation of Bristol-Myers Squibb (Sales Revenue, Cost, Gross Margin)
Table Jamieson Overview List
Table Cyanocobalamin Business Operation of Jamieson (Sales Revenue, Cost, Gross Margin)
Table Jamieson Overview List
Table Cyanocobalamin Business Operation of Jamieson (Sales Revenue, Cost, Gross Margin)
Table Teva (Actavis) Overview List
Table Cyanocobalamin Business Operation of Teva (Actavis) (Sales Revenue, Cost, Gross Margin)
Table Merck Overview List
Table Cyanocobalamin Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table Mylan Overview List
Table Cyanocobalamin Business Operation of Mylan (Sales Revenue, Cost, Gross Margin)
Table Bayer HealthCare Overview List
Table Cyanocobalamin Business Operation of Bayer HealthCare (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table Cyanocobalamin Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table ANGELINI Overview List
Table Cyanocobalamin Business Operation of ANGELINI (Sales Revenue, Cost, Gross Margin)
Table Biological E Overview List
Table Cyanocobalamin Business Operation of Biological E (Sales Revenue, Cost, Gross Margin)
Table CCEPCD Overview List
Table Cyanocobalamin Business Operation of CCEPCD (Sales Revenue, Cost, Gross Margin)
Table Huaxin Pharmaceutical Overview List
Table Cyanocobalamin Business Operation of Huaxin Pharmaceutical (Sales Revenue, Cost, Gross Margin)
Table Global Cyanocobalamin Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Cyanocobalamin Sales Revenue Share, by Companies, in USD Million
Table Cyanocobalamin Demand 2012-2017, by Application, in USD Million
Table Cyanocobalamin Demand Forecast 2018-2023, by Application, in USD Million
Table Global Cyanocobalamin Market 2012-2017, by Region, in USD Million
Table Cyanocobalamin Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Cyanocobalamin Industry Chain Structure
Figure Global Cyanocobalamin Market Growth 2012-2017, by Type, in USD Million
Figure Global Cyanocobalamin Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region